B-type natriuretic protein/N-terminal pro b-type natriuretic peptide IVD, kit, fluorescent immunoassay
- UID
- IMP/IVD/2022/000064_607f5c611414c84d5d460dfba4c424da_a1f883c56682d9cba833b6f61ae67982
- Device class
- Class C
- Brand name
- Quidel Triage® TOX Drug Screen, 94600 Control 2
- License holder
- Quidel Diagnostics India Pvt Ltd
- Approving authority
- CDSCO
- Product information
- The Quidel Triage BNP Test is a rapid, point of care fluorescence immunoassay to be used with the Quidel Triage Meters for the quantitative measurement of B-type natriuretic peptide (Quidel Triage® TOX Drug Screen, 94600 Control 2) in EDTA anticoagulated whole blood or plasma specimens. The test is intended to be used as an aid in the diagnosis and assessment of severity of congestive heart failure (Quidel Triage® TOX Drug Screen, 94600 Control 2). The test also is used for the risk stratification of patients with acute coronary syndromes and for the risk stratification of patients with heart failure
B-type natriuretic protein/N-terminal pro b-type natriuretic peptide IVD, kit, fluorescent immunoassay is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2022/000064_607f5c611414c84d5d460dfba4c424da_a1f883c56682d9cba833b6f61ae67982. This device is marketed under the brand name Quidel Triage® TOX Drug Screen, 94600 Control 2. The license holder is Quidel Diagnostics India Pvt Ltd, and it is classified as Device Class Class C. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.